Your Location:
Home >
Browse articles >
Clinical Application and Pharmacological Mechanism of Sishenwan in Treatment of Ulcerative Colitis: A Review
Clinical Application and Pharmacological Mechanism of Sishenwan in Treatment of Ulcerative Colitis: A Review
Enhanced Publication- “In the field of ulcerative colitis treatment, Sishen Wan has demonstrated clinical advantages in regulating spleen kidney yang deficiency type UC, providing theoretical basis for integrated treatment of traditional Chinese and Western medicine.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 21, Pages: 261-270(2025)
DOI: 10.13422/j.cnki.syfjx.20251009
Revised:2025-06-03 ,
Accepted:17 June 2025
Scan QR Code
AI Introduction
Full Text(HTML)
References
Publication Info
Metrics
767
Views
1401
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Huangqintang in Treatment of Ulcerative Colitis: A Review
Effect of Sishenwan on Toll-like Receptor 4 and IRAK-M Expression in Colonic Tissue of Rats with Ulcerative Colitis of Spleen-kidney Yang Deficiency Type
Exploring Clinical Application and Mechanism of Huangqi Guizhi Wuwutang Based on Theory of Treating Different Diseases with Same Method
Clinical Application and Mechanism Insights of Xiaoyao San in Treating Ophthalmic Disorders From Theory of Treating Different Diseases with Same Method
Effect of Shengui Jiangtang Formula on Glucose and Lipid Metabolism in Type 2 Diabetic db/db Mice via PI3K/Akt/FoxO1 Signaling Pathway and Underlying Mechanisms
Related Author
SUN Haoxian
SUN Guixiang
ZHU Ying
Ai-hua WANG
Lan-juan HE
Xiang-dong ZHU
ZHANG Jiali
ZHANG Yubin
Related Institution
Hunan University of Chinese Medicine
The First Hospital of Hunan University of Chinese Medicine
Gansu Provincial Hospital of Traditional Chinese Medicine
Gansu University of Chinese Medicine
College of Orthopedics and Traumatology,Henan University of Chinese Medicine


